Literature DB >> 7769682

Defective accessory genes in a human immunodeficiency virus type 1-infected long-term survivor lacking recoverable virus.

N L Michael1, G Chang, L A d'Arcy, P K Ehrenberg, R Mariani, M P Busch, D L Birx, D H Schwartz.   

Abstract

We have been studying a patient who acquired human immunodeficiency virus (HIV) infection via a blood transfusion 13 years ago. She has remained asymptomatic since that time. The blood donor and two other recipients have all died of AIDS. Although this patient has shown persistently strong seroreactivity to HIV type 1 (HIV-1) antigens by Western blot (immunoblot), she has been continually HIV culture negative in results from multiple laboratories over the last 6 years and has a very low viral burden. Her CD4+ T-cell count has fluctuated around a mean of 399 cells per microliters, with little change in lymphocyte subset percentages. Strong cellular immune responses to HIV-1 epitopes by this patient have been demonstrated. We now report the results of an intensive molecular genetic analysis of the HIV-1 proviral quasispecies from this patient sampled over 5 years. Long terminal repeat region sequences supported the argument for normal basal and Tat-mediated promoter activities. Sequential sequencing of the nef gene revealed a low frequency (8.3%) of defective genes and a striking lack of sequence evolution. Functional analysis of predominant nef genes by both a cell surface CD4 downregulation and a viral infectivity complementation assay showed wild-type function. In contrast, sequential analysis of an amplicon containing the vif, vpr, vpu, tat1, and rev1 genes revealed the presence of inactivating mutations in 64% of the clones. These data suggest that this patient, initially infected with a virulent swarm of HIV-1, is presently infected with a more-attenuated viral quasispecies as a result of effective host immunity.

Entities:  

Mesh:

Year:  1995        PMID: 7769682      PMCID: PMC189160          DOI: 10.1128/JVI.69.7.4228-4236.1995

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  62 in total

1.  Regulation of human immunodeficiency virus Nef protein by phosphorylation.

Authors:  J C Bandres; S Luria; L Ratner
Journal:  Virology       Date:  1994-05-15       Impact factor: 3.616

Review 2.  The immunopathogenesis of human immunodeficiency virus infection.

Authors:  G Pantaleo; C Graziosi; A S Fauci
Journal:  N Engl J Med       Date:  1993-02-04       Impact factor: 91.245

3.  Cell-free transmission of Vif mutants of HIV-1.

Authors:  L Fan; K Peden
Journal:  Virology       Date:  1992-09       Impact factor: 3.616

4.  Predictors of rapid progression to AIDS in HIV-1 seroconverters.

Authors:  I P Keet; P Krijnen; M Koot; J M Lange; F Miedema; J Goudsmit; R A Coutinho
Journal:  AIDS       Date:  1993-01       Impact factor: 4.177

5.  Cell-dependent requirement of human immunodeficiency virus type 1 Vif protein for maturation of virus particles.

Authors:  H Sakai; R Shibata; J Sakuragi; S Sakuragi; M Kawamura; A Adachi
Journal:  J Virol       Date:  1993-03       Impact factor: 5.103

6.  Human immunodeficiency virus type 1 Vpu protein induces rapid degradation of CD4.

Authors:  R L Willey; F Maldarelli; M A Martin; K Strebel
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

7.  Human immunodeficiency virus type 1 Vpu protein induces degradation of CD4 in vitro: the cytoplasmic domain of CD4 contributes to Vpu sensitivity.

Authors:  M Y Chen; F Maldarelli; M K Karczewski; R L Willey; K Strebel
Journal:  J Virol       Date:  1993-07       Impact factor: 5.103

8.  Human immunodeficiency virus type 1 Vpu has a CD4- and an envelope glycoprotein-independent function.

Authors:  R J Geraghty; A T Panganiban
Journal:  J Virol       Date:  1993-07       Impact factor: 5.103

9.  Altered T cell activation and development in transgenic mice expressing the HIV-1 nef gene.

Authors:  J Skowronski; D Parks; R Mariani
Journal:  EMBO J       Date:  1993-02       Impact factor: 11.598

10.  Downregulation of cell-surface CD4 expression by simian immunodeficiency virus Nef prevents viral super infection.

Authors:  R E Benson; A Sanfridson; J S Ottinger; C Doyle; B R Cullen
Journal:  J Exp Med       Date:  1993-06-01       Impact factor: 14.307

View more
  41 in total

1.  Dynamics of HIV-1 mRNA expression in patients with long-term nonprogressive HIV-1 infection.

Authors:  M Comar; C Simonelli; S Zanussi; P Paoli; E Vaccher; U Tirelli; M Giacca
Journal:  J Clin Invest       Date:  1997-08-15       Impact factor: 14.808

2.  Mutational analysis of human immunodeficiency virus type 1 (HIV-1) accessory genes: requirement of a site in the nef gene for HIV-1 replication in activated CD4+ T cells in vitro and in vivo.

Authors:  Y Kawano; Y Tanaka; N Misawa; R Tanaka; J I Kira; T Kimura; M Fukushi; K Sano; T Goto; M Nakai; T Kobayashi; N Yamamoto; Y Koyanagi
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

3.  Genetic analysis of the long terminal repeat (LTR) promoter region in HIV-1-infected individuals with different rates of disease progression.

Authors:  Eva Ramírez de Arellano; Cristina Martín; Vincent Soriano; José Alcamí; Africa Holguín
Journal:  Virus Genes       Date:  2006-12-09       Impact factor: 2.332

Review 4.  Unravelling the mechanisms of durable control of HIV-1.

Authors:  Bruce D Walker; Xu G Yu
Journal:  Nat Rev Immunol       Date:  2013-07       Impact factor: 53.106

5.  Grossly defective nef gene sequences in a human immunodeficiency virus type 1-seropositive long-term nonprogressor.

Authors:  R Salvi; A R Garbuglia; A Di Caro; S Pulciani; F Montella; A Benedetto
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

6.  Recombinant human immunodeficiency virus type 1 genomes with tat unconstrained by overlapping reading frames reveal residues in Tat important for replication in tissue culture.

Authors:  C Neuveut; K T Jeang
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

Review 7.  Immunity to retroviral infection: the Friend virus model.

Authors:  K J Hasenkrug; B Chesebro
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-22       Impact factor: 11.205

8.  Functional characterization of human immunodeficiency virus type 1 nef genes in patients with divergent rates of disease progression.

Authors:  N L Michael; G Chang; L A d'Arcy; C J Tseng; D L Birx; H W Sheppard
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

9.  Human immunodeficiency virus type 1 Vpr: oligomerization is an essential feature for its incorporation into virus particles.

Authors:  Narasimhan J Venkatachari; Leah A Walker; Oznur Tastan; Thien Le; Timothy M Dempsey; Yaming Li; Naveena Yanamala; Alagarsamy Srinivasan; Judith Klein-Seetharaman; Ronald C Montelaro; Velpandi Ayyavoo
Journal:  Virol J       Date:  2010-06-07       Impact factor: 4.099

10.  The immunosuppressive properties of the HIV Vpr protein are linked to a single highly conserved residue, R90.

Authors:  Irina Tcherepanova; Aijing Starr; Brad Lackford; Melissa D Adams; Jean-Pierre Routy; Mohamed Rachid Boulassel; David Calderhead; Don Healey; Charles Nicolette
Journal:  PLoS One       Date:  2009-06-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.